Charles River Laboratories Receivables 2010-2024 | CRL

Charles River Laboratories receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • Charles River Laboratories receivables for the quarter ending September 30, 2024 were $0.754B, a 5.64% decline year-over-year.
  • Charles River Laboratories receivables for 2023 were $0.78B, a 3.72% increase from 2022.
  • Charles River Laboratories receivables for 2022 were $0.752B, a 17.03% increase from 2021.
  • Charles River Laboratories receivables for 2021 were $0.643B, a 4.07% increase from 2020.
Charles River Laboratories Annual Receivables
(Millions of US $)
2023 $780
2022 $752
2021 $643
2020 $618
2019 $514
2018 $472
2017 $430
2016 $364
2015 $270
2014 $258
2013 $221
2012 $203
2011 $185
2010 $193
2009 $190
Charles River Laboratories Quarterly Receivables
(Millions of US $)
2024-09-30 $754
2024-06-30 $762
2024-03-31 $787
2023-12-31 $780
2023-09-30 $799
2023-06-30 $801
2023-03-31 $788
2022-12-31 $752
2022-09-30 $771
2022-06-30 $748
2022-03-31 $698
2021-12-31 $643
2021-09-30 $660
2021-06-30 $644
2021-03-31 $611
2020-12-31 $618
2020-09-30 $572
2020-06-30 $533
2020-03-31 $542
2019-12-31 $514
2019-09-30 $524
2019-06-30 $545
2019-03-31 $496
2018-12-31 $472
2018-09-30 $487
2018-06-30 $479
2018-03-31 $440
2017-12-31 $430
2017-09-30 $422
2017-06-30 $399
2017-03-31 $384
2016-12-31 $364
2016-09-30 $360
2016-06-30 $346
2016-03-31 $287
2015-12-31 $270
2015-09-30 $289
2015-06-30 $277
2015-03-31 $265
2014-12-31 $258
2014-09-30 $275
2014-06-30 $275
2014-03-31 $240
2013-12-31 $221
2013-09-30 $224
2013-06-30 $224
2013-03-31 $214
2012-12-31 $203
2012-09-30 $216
2012-06-30 $208
2012-03-31 $206
2011-12-31 $185
2011-09-30 $202
2011-06-30 $212
2011-03-31 $215
2010-12-31 $193
2010-09-30 $217
2010-06-30 $219
2010-03-31 $220
2009-12-31 $190
2009-09-30 $213
2009-06-30 $210
2009-03-31 $211
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00